Evidence map›Paper›PMID 21113400›Full record

ArticleGenes & cancer2010

Ubiquitin and ubiquitin-like proteins in the nucleolus: multitasking tools for a ribosome factory.

Natalia Shcherbik, Dimitri G Pestov

Open access · greenAbstract read
In one paragraph

Article in Genes & cancer, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 27 citations in OpenAlex.

  1. Article
  2. A ubiquitin language communicates ribosomal distress.Seminars in cell & developmental biology · 2024
    Review
  3. Article
  4. Article
  5. Review
  6. Advances on Plant Ubiquitylome-From Mechanism to Application.International journal of molecular sciences · 2020
    Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Review
  15. Article
  16. Orc2 protects ORCA from ubiquitin-mediated degradation.Cell cycle (Georgetown, Tex.) · 2012
    Article
  17. Article
  18. Article
  19. Ubiquitin and proteasomes in transcription.Annual review of biochemistry · 2012
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Natalia ShcherbikDepartment of Cell Biology, University of Medicine and Dentistry of New Jersey, Stratford, NJ 08084.
Dimitri G Pestov
Stratford University · US

Funding

Monitoring mechanisms in mammalian ribosome biogenesisR01GM074091 · NIGMS · UNIV OF MED/DENT NJ-SCH OSTEOPATHIC MED · PI PESTOV, DIMITRI G · 2005 to 2014
$2.4M
NIGMS NIH HHS R01 GM074091
6 · The paper itself

Abstract

Synthesis of new ribosomes is an essential process upregulated during cell growth and proliferation. Here, we review our current understanding of the role that ubiquitin and ubiquitin-like proteins (UBLs) play in ribosome biogenesis, with a focus on mammalian cells. One important function of the nuclear ubiquitin-proteasome system is to control the supply of ribosomal proteins for the assembly of new ribosomal subunits in the nucleolus. Mutations in ribosomal proteins or ribosome assembly factors, stress, and many anticancer drugs have been shown to disrupt normal ribosome biogenesis, triggering a p53-dependent response. We discuss how p53 can be activated by the aberrant ribosome formation, centering on the current models of the interaction between ribosomal proteins released from the nucleolus and the ubiquitin ligase Mdm2. Recent studies also revealed multiple ubiquitin- and UBL-conjugated forms of nucleolar proteins with largely unknown functions, indicating that many new details about the role of these modifications in the nucleolus await to be discovered.

Identifiers

PMID21113400
PMCPMC2991155
OpenAlexW2163678080

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.